Sterivet Laboratories Ltd U.S. Food Drug Administration grant expedite review status proprietary drug Navicon. The company future marketability Navicon U.S. greatly facilitate receive expedite review status company achieve wide penetration FDA approval drug received. Navicon drug design treat navicular disease affect foot one-third horse age five 15. Reuter 